Intramuscular diazepam pharmacokinetics in soman-exposed guinea pigs

Area of Science:

• Pharmacology
• Neuroscience
• Toxicology

Background:

• Intramuscular diazepam is a U.S. military standard for treating organophosphorus nerve agent (OPNA) intoxication.
• OPNA exposure can cause severe neurological effects, including seizures, necessitating rapid and effective anticonvulsant therapy.

Purpose of the Study:

• To investigate the pharmacokinetics and pharmacodynamics of intramuscular diazepam in soman-exposed guinea pigs.
• To determine the efficacy of diazepam in terminating seizure activity induced by soman poisoning.

Main Methods:

• Guinea pigs were pretreated with pyridostigmine, exposed to soman, and treated with atropine and pralidoxime.
• Electroencephalogram (EEG) monitoring was used to assess seizure activity.
• Diazepam (10 mg x kg(-1) i.m.) was administered post-seizure onset, and serial blood samples were collected for pharmacokinetic analysis.

Main Results:

• Diazepam terminated seizure activity in 52% of soman-exposed guinea pigs within 30 minutes.
• Pharmacokinetics followed a one-compartment model with first-order absorption and elimination.
• Plasma concentrations (Cmax) were higher in seizure-terminated animals (991 ng x ml(-1)) compared to non-terminated animals (839 ng x ml(-1)), with significant differences noted at 30 minutes.

Conclusions:

• Intramuscular diazepam at 10 mg x kg(-1) is partially effective in terminating soman-induced seizures in guinea pigs.
• The observed Cmax in seizure-terminated animals aligns with therapeutic ranges in humans, suggesting dose-dependency.
• Higher diazepam doses and resulting plasma concentrations may be required to achieve complete seizure termination following OPNA exposure.